Advertisement

Topics

Taisho Pharmaceutical Holdings Co Ltd Strategy, SWOT and Corporate Finance Report [Report Updated: 28082018] Prices from USD $175

02:56 EDT 23 Oct 2018 | BioPortfolio Reports

Taisho Pharmaceutical Holdings Co Ltd Strategy, SWOT and Corporate Finance Report


Summary


Taisho Pharmaceutical Holdings Co Ltd Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.


Key Highlights


Taisho Pharmaceutical Holdings Co Ltd Taisho Pharmaceutical develops, manufactures and markets selfmedication drugs and prescription pharmaceuticals. Its selfmedication products comprise overthecounter OTC products, quasidrugs and health food products. The company's prescription pharmaceuticals portfolio includes ethical drugs in the fields of infectious diseases, orthopedic disorders, central nervous system CNS diseases and metabolic diseases. Taisho Pharmaceutical also has various products in pipeline such as TS091 for central disorders of hypersomnolence; TS141 for childhood attentiondeficit/hyperactivity disorder; TS121 for depression; and TS133 for alopecia, among others. It distributes products through its subsidiaries located in the Philippines, Indonesia, Malaysia, Thailand, Vietnam, China, Singapore, Taiwan, and the US. Taisho Pharmaceutical is headquartered in Toshimaku, Tokyo, Japan.


Scope


Detailed information on Taisho Pharmaceutical Holdings Co Ltd required for business and competitor intelligence needs

A study of the major internal and external factors affecting Taisho Pharmaceutical Holdings Co Ltd in the form of a SWOT analysis

An indepth view of the business model of Taisho Pharmaceutical Holdings Co Ltd including a breakdown and examination of key business segments

Intelligence on Taisho Pharmaceutical Holdings Co Ltd's mergers and acquisitions MandA, strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

News about Taisho Pharmaceutical Holdings Co Ltd, such as business expansion, restructuring, and contract wins

Large number of easytograsp charts and graphs that present important data and key trends


Reasons to buy


Gain understanding of Taisho Pharmaceutical Holdings Co Ltd and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Taisho Pharmaceutical Holdings Co Ltd as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Taisho Pharmaceutical Holdings Co Ltd's business structure, strategy and prospects.

Original Article: Taisho Pharmaceutical Holdings Co Ltd Strategy, SWOT and Corporate Finance Report [Report Updated: 28082018] Prices from USD $175

NEXT ARTICLE

More From BioPortfolio on "Taisho Pharmaceutical Holdings Co Ltd Strategy, SWOT and Corporate Finance Report [Report Updated: 28082018] Prices from USD $175"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Food
Food is any substance consumed to provide nutritional support for the body. It is usually of plant or animal origin, and contains essential nutrients, such as carbohydrates, fats, proteins, vitamins, or minerals. The substance is ingested by an organism ...